Double maintains 2 strategies that include HROW - Harrow, Inc.
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| XPEL | 64.06% | $1.07B | +16.95% | 0.00% |
| ICUI | 60.30% | $3.35B | +15.43% | 0.00% |
| HCAT | 58.64% | $282.58M | -34.30% | 0.00% |
| KVYO | 56.76% | $9.07B | +34.36% | 0.00% |
| XMTR | 54.34% | $1.66B | +178.52% | 0.00% |
| ACVA | 53.48% | $2.84B | -6.47% | 0.00% |
| Z | 52.80% | $17.14B | +55.02% | 0.00% |
| CMPO | 52.30% | $1.50B | +151.82% | 0.00% |
| ZG | 52.15% | $16.65B | +55.43% | 0.00% |
| PH | 50.95% | $90.91B | +38.76% | 0.94% |
| CLPT | 50.53% | $319.11M | +110.24% | 0.00% |
| SKYT | 50.29% | $526.01M | +48.58% | 0.00% |
| DGII | 50.22% | $1.32B | +56.65% | 0.00% |
| CPRX | 49.77% | $2.62B | +40.10% | 0.00% |
| MATV | 49.38% | $403.74M | -55.24% | 5.49% |
| AMRX | 49.18% | $2.62B | +24.00% | 0.00% |
| YETI | 46.43% | $2.76B | -10.53% | 0.00% |
| HIPO | 45.37% | $694.33M | +75.68% | 0.00% |
| PAR | 44.92% | $2.72B | +44.25% | 0.00% |
| EBS | 44.70% | $385.92M | -5.70% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| BTCT | 0.01% | $25.56M | +61.14% | 0.00% |
| HTO | -0.01% | $1.82B | -0.39% | 3.10% |
| GIS | 0.05% | $29.20B | -14.66% | 4.47% |
| DFDV | 0.20% | $300.56M | +2,130.16% | 0.00% |
| PULM | -0.20% | $25.57M | +219.63% | 0.00% |
| MSIF | 0.21% | $769.47M | +36.17% | 7.61% |
| PG | -0.24% | $377.94B | -1.61% | 2.53% |
| NEUE | 0.47% | $61.24M | +29.92% | 0.00% |
| COR | 0.57% | $56.44B | +30.86% | 0.74% |
| WTRG | -0.61% | $10.40B | +1.01% | 3.50% |
| HAE | 0.67% | $3.66B | -9.38% | 0.00% |
| FE | 0.71% | $22.95B | +3.43% | 4.32% |
| LUMN | 0.76% | $4.57B | +327.88% | 0.00% |
| DAO | 0.78% | $262.76M | +119.32% | 0.00% |
| VITL | 0.79% | $1.76B | -11.92% | 0.00% |
| REYN | -0.86% | $4.59B | -20.51% | 4.22% |
| MOH | 0.87% | $12.95B | -19.36% | 0.00% |
| GHG | 1.01% | $162.90M | -2.79% | 0.00% |
| CCI | -1.03% | $44.93B | +6.73% | 5.62% |
| FDP | -1.14% | $1.59B | +52.62% | 3.31% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -34.99% | $99.63M | 0.59% |
| BTAL | -34.69% | $296.22M | 1.43% |
| VIXY | -34.55% | $164.54M | 0.85% |
| IVOL | -21.78% | $347.03M | 1.02% |
| XONE | -17.77% | $625.28M | 0.03% |
| SPTS | -15.46% | $5.80B | 0.03% |
| XHLF | -15.46% | $1.73B | 0.03% |
| IBTG | -14.07% | $1.92B | 0.07% |
| TFLO | -13.46% | $6.82B | 0.15% |
| FTSD | -13.12% | $231.81M | 0.25% |
| IBTH | -12.49% | $1.62B | 0.07% |
| UTWO | -11.96% | $379.52M | 0.15% |
| FXY | -10.76% | $816.38M | 0.4% |
| VGSH | -10.44% | $22.80B | 0.03% |
| SCHO | -9.96% | $11.03B | 0.03% |
| IBTI | -9.30% | $1.06B | 0.07% |
| LDUR | -9.23% | $929.65M | 0.5% |
| STPZ | -8.59% | $450.47M | 0.2% |
| TPMN | -8.56% | $30.70M | 0.65% |
| ULST | -8.29% | $654.75M | 0.2% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MCK | -20.49% | $88.11B | +20.93% | 0.40% |
| MNST | -14.32% | $61.48B | +28.23% | 0.00% |
| FROG | -14.29% | $4.74B | +15.86% | 0.00% |
| BMBL | -13.22% | $684.82M | -31.65% | 0.00% |
| CDLX | -13.00% | $94.50M | -78.34% | 0.00% |
| ED | -10.96% | $36.00B | +12.64% | 3.34% |
| CBOE | -10.05% | $24.23B | +35.36% | 1.09% |
| CME | -9.83% | $99.39B | +40.68% | 3.86% |
| AEP | -9.60% | $55.16B | +17.93% | 3.54% |
| CCEC | -9.32% | $1.02B | +3.91% | 2.58% |
| DUK | -8.16% | $90.99B | +17.25% | 3.56% |
| CIG.C | -7.84% | $2.65B | +29.61% | 0.00% |
| CYCN | -6.68% | $10.59M | +46.35% | 0.00% |
| AMT | -6.64% | $104.32B | +14.40% | 3.00% |
| IRWD | -6.54% | $119.70M | -87.89% | 0.00% |
| RAMP | -6.40% | $2.15B | +3.64% | 0.00% |
| AWK | -6.37% | $27.36B | +9.65% | 2.21% |
| EXC | -5.84% | $43.33B | +23.58% | 3.62% |
| SO | -5.40% | $100.18B | +17.28% | 3.18% |
| PM | -5.14% | $273.81B | +73.45% | 3.06% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| PTH | 49.01% | $100.85M | 0.6% |
| RDTE | 48.38% | $137.93M | 0.97% |
| QDVO | 48.13% | $83.43M | 0.55% |
| IWO | 46.76% | $11.60B | 0.24% |
| KOMP | 46.57% | $2.29B | 0.2% |
| SECT | 46.41% | $2.10B | 0.78% |
| HEQT | 46.37% | $331.62M | 0.44% |
| QQQJ | 46.30% | $621.52M | 0.15% |
| ISCG | 45.96% | $681.20M | 0.06% |
| DUHP | 45.78% | $8.66B | 0.21% |
| FXL | 45.62% | $1.37B | 0.62% |
| VBK | 45.56% | $19.01B | 0.07% |
| XPH | 45.55% | $147.96M | 0.35% |
| SFLR | 45.31% | $853.90M | 0.89% |
| FLQL | 45.24% | $1.52B | 0.29% |
| IPO | 45.24% | $143.77M | 0.6% |
| JMOM | 45.13% | $1.56B | 0.12% |
| FNY | 45.12% | $383.06M | 0.7% |
| KJUL | 45.10% | $119.50M | 0.79% |
| IWM | 45.07% | $63.72B | 0.19% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| JPLD | -0.01% | $1.77B | 0.24% |
| VGLT | 0.06% | $9.85B | 0.04% |
| CORN | 0.07% | $44.67M | 0.2% |
| TOTL | -0.13% | $3.84B | 0.55% |
| KRBN | 0.14% | $160.17M | 0.85% |
| FMHI | -0.16% | $754.85M | 0.7% |
| FLDR | -0.19% | $941.22M | 0.15% |
| KMLM | -0.24% | $188.90M | 0.9% |
| IBMN | -0.29% | $447.08M | 0.18% |
| IBDQ | -0.34% | $2.98B | 0.1% |
| USDU | 0.37% | $162.43M | 0.5% |
| SPTL | 0.37% | $11.44B | 0.03% |
| GVI | 0.39% | $3.42B | 0.2% |
| TLT | 0.53% | $48.41B | 0.15% |
| YEAR | -0.53% | $1.47B | 0.25% |
| BIL | 0.54% | $42.24B | 0.1356% |
| CGSD | 0.57% | $1.32B | 0.25% |
| CARY | 0.59% | $347.36M | 0.8% |
| TLH | 0.62% | $11.52B | 0.15% |
| DFIP | 0.65% | $925.62M | 0.11% |
Current Value
$30.901 Year Return
Current Value
$30.901 Year Return
Yahoo
Investors need to pay close attention to HROW stock based on the movements in the options market lately.
Yahoo
We feel now is a pretty good time to analyse Harrow, Inc.'s ( NASDAQ:HROW ) business as it appears the company may be...
Yahoo
NASHVILLE, Tenn., June 18, 2025--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that Mike Biega has joined Harrow as Vice President of Investor Relations and Communications, succeeding Jamie Webb, Director of Communications and Investor Relations, who recently announced her retirement. Jamie will remain in her role into August to support a smooth and effective transition.
SeekingAlpha
Discover top fixed income strategies for steady dividends and +7% yields. Read more about how patience and strategy can lead to excellent total returns.
Yahoo
NASHVILLE, Tenn. & TAIPEI, Taiwan, June 09, 2025--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW), today announced a licensing agreement, whereby Harrow has acquired the exclusive U.S. commercial rights for BYQLOVI™ (clobetasol propionate ophthalmic suspension) 0.05%. BYQLOVI was recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of post-operative inflammation and pain fo
Finnhub
Formosa Pharmaceuticals Inc: * HARROW ACQUIRES U.S. COMMERCIAL RIGHTS TO BYQLOVI™ 0.05% FROM FORMOSAPHARMACEUTICALS *...
